$1.26
+0.01 (+0.80%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+123.8% upside
Low Target
$1.78
Average Target
$2.82
High Target
$3.37
Current Price
$1.26
Current
$1.26
$1.26
Target
$2.82
$2.82
$1.78
$2.82 avg
$3.37
Scenario Analysis
Bear Case
$1.78
41.3%
Low target
Base Case
$2.82
+123.8%
Avg target
Bull Case
$3.37
+167.5%
High target
Risk/Reward
4.1x
Highly favorable
Price in Context
52-Week High
$2.99
-57.9% from high
52-Week Low
$0.87
+44.5% from low
Target vs 52W High
$2.82
-5.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |